BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness.
The death of a nurse marked the moment health officials recognized that something dangerous was spreading. The illness was Bundibugyo virus, a rare but potentially deadly infection now driving a growing outbreak in the Democratic Republic of Congo and exposing how poorly prepared health systems can be for diseases that receive little attention between emergencies.
Boston University professor Nancy Sullivan examines that vulnerability in a review published in the New England Journal of Medicine. She argues that the outbreak should serve as a warning: planning cannot focus only on the infectious threats most likely to make headlines.
Bundibugyo belongs to the filovirus family, a group of viruses that includes the better-known Ebola virus. Before the current crisis, health officials had recognized only two Bundibugyo outbreaks—in Uganda in 2007 and the Democratic Republic of Congo (DRC) in 2012—but the latest outbreak has already surpassed both in its pace and size. According to the WHO, 695 cases and 138 deaths had been confirmed in the DRC and Uganda as of June 11.
Delays weaken outbreak control
Stopping a virus like Bundibugyo depends on speed. Sullivan, a Boston University professor of biology and virology, immunology & microbiology, explains that health workers must quickly identify infections, separate patients from others, trace people who may have been exposed, strengthen infection-control measures, and provide supportive care.
Each step helps break a different link in the chain of transmission. Yet in places with limited laboratory resources, even determining what disease a patient has can take too long. Testing delays can leave infected people in contact with family members, caregivers, and other patients while the virus continues spreading.
Bundibugyo causes severe hemorrhagic fever, an illness that can trigger widespread inflammation, damage the inner lining of blood vessels, produce uncontrolled bleeding, and lead to the failure of several organs. The virus passes through direct contact with infected bodily fluids, placing caregivers at particular risk, especially inside hospitals. The 2026 outbreak was formally identified after a nurse died.
Diagnosis presents one of the greatest obstacles. Early symptoms can look much like malaria, typhoid fever and several other illnesses, so doctors cannot reliably identify Bundibugyo from symptoms alone. Laboratory confirmation is essential, Sullivan said.
That requirement creates a logistical problem in the DRC. Limited local testing capacity means samples may need to travel considerable distances to national reference laboratories, the centralized facilities equipped to confirm difficult or dangerous infections.
"Delays in specimen collection, transportation and testing can postpone confirmation by days or weeks, which hinders the isolation of infected persons, contact tracing and the initiation of outbreak-control measures," Sullivan wrote.
Rare pathogens expose preparedness gaps
The outbreak reveals a broader weakness in infectious disease planning. Preparedness programs often concentrate resources on pathogens considered the most common or most likely to cause a major emergency. Bundibugyo shows why that strategy can leave dangerous blind spots.
After decades with little recognized activity, the virus has returned as a serious threat. Its reappearance illustrates how difficult it is to predict which pathogen will drive the next outbreak. Sullivan has called for countermeasures that can address any virus capable of causing severe illness or death in humans, rather than waiting until a neglected disease begins spreading widely.
Researchers have made progress on vaccines and treatments for the Ebola, Sudan, and Marburg viruses. Bundibugyo occurs far less often, however, and no licensed vaccine or therapy has been developed specifically for it. Evidence indicates that vaccines designed for other virus species may offer some protection, but that possibility does not replace the need for dedicated preparation.
"Preparedness planning should extend beyond diagnostics, vaccines, and therapeutics to include operational readiness for multinational outbreak response," she said.
Reference: "Bundibugyo Virus Disease in 2026 — Clinical and Public Health Responses" by Nancy J. Sullivan, 23 June 2026, New England Journal of Medicine.
DOI: 10.1056/NEJMra2607216
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
Aging Cells May Be Hiding From the Immune System – Scientists Think They Know How
Your immune system is supposed to clear out damaged cells. Researchers may have found how some of them hide and linger as the body ages. Researchers led by Cedars-Sinai Health Sciences University have identified [...]
Your Voice May Reveal How Fast Your Brain Is Aging
Researchers have developed a machine-learning “speech clock” that estimates age from subtle patterns in how people speak and what they say. It is possible that people’s voices may contain certain signals of aging that [...]
Optogenetics Pioneers Win 2026 Nobel Prize in Physiology or Medicine
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Peter Hegemann, Georg Nagel, and Karl Deisseroth for the development of optogenetics, a revolutionary technology that uses light to control individual neurons [...]
Molecular Manufacturing: The Future of Nanomedicine – From NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
What is ‘American Covid’ and how bad is it?
Cases of so-called ‘American Covid’ are on the rise in the UK. The strain is officially called XFG, or ‘Stratus’, and is the most common variant in North America, hence the name. It might soon [...]
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
